Correction to: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1)

Laura Riva; Shuofeng Yuan; Xin Yin; Laura Martin-Sancho; Naoko Matsunaga; Lars Pache; Sebastian Burgstaller-Muehlbacher; Paul D. De Jesus; Peter Teriete; Mitchell V. Hull; Max W. Chang; Jasper Fuk Woo Chan; Jianli Cao; Vincent Kwok Man Poon; Kristina M. Herbert; Kuoyuan Cheng; Tu Trinh H. Nguyen; Andrey Rubanov; Yuan Pu; Courtney Nguyen; Angela Choi; Raveen Rathnasinghe; Michael Schotsaert; Lisa Miorin; Marion Dejosez; Thomas P. Zwaka; Ko Yung Sit; Luis Martinez-Sobrido; Wen Chun Liu; Kris M. White; Mackenzie E. Chapman; Emma K. Lendy; Richard J. Glynne; Randy Albrecht; Eytan Ruppin; Andrew D. Mesecar; Jeffrey R. Johnson; Christopher Benner; Ren Sun; Peter G. Schultz; Andrew I. Su; Adolfo García-Sastre; Arnab K. Chatterjee; Kwok Yung Yuen; Sumit K. Chanda

doi:10.1038/s41586-024-07659-8

Correction to: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1)

Laura Riva
, Shuofeng Yuan
, Xin Yin
, Laura Martin-Sancho
, Naoko Matsunaga
, Lars Pache
, Sebastian Burgstaller-Muehlbacher
, Paul D. De Jesus
, Peter Teriete
, Mitchell V. Hull
, Max W. Chang
, Jasper Fuk Woo Chan
, Jianli Cao
, Vincent Kwok Man Poon
, Kristina M. Herbert
, Kuoyuan Cheng
, Tu Trinh H. Nguyen
, Andrey Rubanov
, Yuan Pu
, Courtney Nguyen

Angela Choi, Raveen Rathnasinghe, Michael Schotsaert, Lisa Miorin, Marion Dejosez, Thomas P. Zwaka, Ko Yung Sit, Luis Martinez-Sobrido, Wen Chun Liu, Kris M. White, Mackenzie E. Chapman, Emma K. Lendy, Richard J. Glynne, Randy Albrecht, Eytan Ruppin, Andrew D. Mesecar, Jeffrey R. Johnson, Christopher Benner, Ren Sun, Peter G. Schultz, Andrew I. Su, Adolfo García-Sastre, Arnab K. Chatterjee, Kwok Yung Yuen, Sumit K. Chanda

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Correction to: Naturehttps://doi.org/10.1038/s41586-020-2577-1 Published online 24 July 2020 We have inadvertently included descriptions of induced pluripotent stems cells (iPSCs) in the manuscript Riva et al (2020), Figs. 4c–e, in text (Evaluation in primary human cell models), methods (Validation of antiviral activity in human iPSC-derived pneumocyte-like cells) and Extended Data Fig. 9, when in fact pneumocytes were derived from H9 human embryonic stem cell lines (hESCs). The use of the human embryonic stem cell H9 (hPSC1) lines was approved by The Mount Sinai Embryonic Stem Cell Research Oversight (ESCRO) committee, which provides oversight of all issues related to derivation and use of human embryonic stem cell (hESC) lines. This error does not impact the interpretations and conclusions of the study.

Original language	English
Pages (from-to)	E3
Journal	Nature
Volume	631
Issue number	8019
DOIs	https://doi.org/10.1038/s41586-024-07659-8
State	Published - 4 Jul 2024

Access to Document

10.1038/s41586-024-07659-8

Cite this

Riva, L., Yuan, S., Yin, X., Martin-Sancho, L., Matsunaga, N., Pache, L., Burgstaller-Muehlbacher, S., De Jesus, P. D., Teriete, P., Hull, M. V., Chang, M. W., Chan, J. F. W., Cao, J., Poon, V. K. M., Herbert, K. M., Cheng, K., Nguyen, T. T. H., Rubanov, A., Pu, Y., ... Chanda, S. K. (2024). Correction to: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1). Nature, 631(8019), E3. https://doi.org/10.1038/s41586-024-07659-8

@article{14b2d335490e4f2796b7b80147170b36,

title = "Correction to: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1)",

abstract = "Correction to: Naturehttps://doi.org/10.1038/s41586-020-2577-1 Published online 24 July 2020 We have inadvertently included descriptions of induced pluripotent stems cells (iPSCs) in the manuscript Riva et al (2020), Figs. 4c{\textendash}e, in text (Evaluation in primary human cell models), methods (Validation of antiviral activity in human iPSC-derived pneumocyte-like cells) and Extended Data Fig. 9, when in fact pneumocytes were derived from H9 human embryonic stem cell lines (hESCs). The use of the human embryonic stem cell H9 (hPSC1) lines was approved by The Mount Sinai Embryonic Stem Cell Research Oversight (ESCRO) committee, which provides oversight of all issues related to derivation and use of human embryonic stem cell (hESC) lines. This error does not impact the interpretations and conclusions of the study.",

author = "Laura Riva and Shuofeng Yuan and Xin Yin and Laura Martin-Sancho and Naoko Matsunaga and Lars Pache and Sebastian Burgstaller-Muehlbacher and \{De Jesus\}, \{Paul D.\} and Peter Teriete and Hull, \{Mitchell V.\} and Chang, \{Max W.\} and Chan, \{Jasper Fuk Woo\} and Jianli Cao and Poon, \{Vincent Kwok Man\} and Herbert, \{Kristina M.\} and Kuoyuan Cheng and Nguyen, \{Tu Trinh H.\} and Andrey Rubanov and Yuan Pu and Courtney Nguyen and Angela Choi and Raveen Rathnasinghe and Michael Schotsaert and Lisa Miorin and Marion Dejosez and Zwaka, \{Thomas P.\} and Sit, \{Ko Yung\} and Luis Martinez-Sobrido and Liu, \{Wen Chun\} and White, \{Kris M.\} and Chapman, \{Mackenzie E.\} and Lendy, \{Emma K.\} and Glynne, \{Richard J.\} and Randy Albrecht and Eytan Ruppin and Mesecar, \{Andrew D.\} and Johnson, \{Jeffrey R.\} and Christopher Benner and Ren Sun and Schultz, \{Peter G.\} and Su, \{Andrew I.\} and Adolfo Garc{\'i}a-Sastre and Chatterjee, \{Arnab K.\} and Yuen, \{Kwok Yung\} and Chanda, \{Sumit K.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2024.",

year = "2024",

month = jul,

day = "4",

doi = "10.1038/s41586-024-07659-8",

language = "English",

volume = "631",

pages = "E3",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Research",

number = "8019",

}

Riva, L, Yuan, S, Yin, X, Martin-Sancho, L, Matsunaga, N, Pache, L, Burgstaller-Muehlbacher, S, De Jesus, PD, Teriete, P, Hull, MV, Chang, MW, Chan, JFW, Cao, J, Poon, VKM, Herbert, KM, Cheng, K, Nguyen, TTH, Rubanov, A, Pu, Y, Nguyen, C, Choi, A, Rathnasinghe, R, Schotsaert, M , Miorin, L, Dejosez, M, Zwaka, TP, Sit, KY, Martinez-Sobrido, L, Liu, WC, White, KM, Chapman, ME, Lendy, EK, Glynne, RJ, Albrecht, R, Ruppin, E, Mesecar, AD, Johnson, JR, Benner, C, Sun, R, Schultz, PG, Su, AI, García-Sastre, A, Chatterjee, AK, Yuen, KY & Chanda, SK 2024, 'Correction to: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1)', Nature, vol. 631, no. 8019, pp. E3. https://doi.org/10.1038/s41586-024-07659-8

TY - JOUR

T1 - Correction to

T2 - Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1)

AU - Riva, Laura

AU - Yuan, Shuofeng

AU - Yin, Xin

AU - Martin-Sancho, Laura

AU - Matsunaga, Naoko

AU - Pache, Lars

AU - Burgstaller-Muehlbacher, Sebastian

AU - De Jesus, Paul D.

AU - Teriete, Peter

AU - Hull, Mitchell V.

AU - Chang, Max W.

AU - Chan, Jasper Fuk Woo

AU - Cao, Jianli

AU - Poon, Vincent Kwok Man

AU - Herbert, Kristina M.

AU - Cheng, Kuoyuan

AU - Nguyen, Tu Trinh H.

AU - Rubanov, Andrey

AU - Pu, Yuan

AU - Nguyen, Courtney

AU - Choi, Angela

AU - Rathnasinghe, Raveen

AU - Schotsaert, Michael

AU - Miorin, Lisa

AU - Dejosez, Marion

AU - Zwaka, Thomas P.

AU - Sit, Ko Yung

AU - Martinez-Sobrido, Luis

AU - Liu, Wen Chun

AU - White, Kris M.

AU - Chapman, Mackenzie E.

AU - Lendy, Emma K.

AU - Glynne, Richard J.

AU - Albrecht, Randy

AU - Ruppin, Eytan

AU - Mesecar, Andrew D.

AU - Johnson, Jeffrey R.

AU - Benner, Christopher

AU - Sun, Ren

AU - Schultz, Peter G.

AU - Su, Andrew I.

AU - García-Sastre, Adolfo

AU - Chatterjee, Arnab K.

AU - Yuen, Kwok Yung

AU - Chanda, Sumit K.

PY - 2024/7/4

Y1 - 2024/7/4

N2 - Correction to: Naturehttps://doi.org/10.1038/s41586-020-2577-1 Published online 24 July 2020 We have inadvertently included descriptions of induced pluripotent stems cells (iPSCs) in the manuscript Riva et al (2020), Figs. 4c–e, in text (Evaluation in primary human cell models), methods (Validation of antiviral activity in human iPSC-derived pneumocyte-like cells) and Extended Data Fig. 9, when in fact pneumocytes were derived from H9 human embryonic stem cell lines (hESCs). The use of the human embryonic stem cell H9 (hPSC1) lines was approved by The Mount Sinai Embryonic Stem Cell Research Oversight (ESCRO) committee, which provides oversight of all issues related to derivation and use of human embryonic stem cell (hESC) lines. This error does not impact the interpretations and conclusions of the study.

AB - Correction to: Naturehttps://doi.org/10.1038/s41586-020-2577-1 Published online 24 July 2020 We have inadvertently included descriptions of induced pluripotent stems cells (iPSCs) in the manuscript Riva et al (2020), Figs. 4c–e, in text (Evaluation in primary human cell models), methods (Validation of antiviral activity in human iPSC-derived pneumocyte-like cells) and Extended Data Fig. 9, when in fact pneumocytes were derived from H9 human embryonic stem cell lines (hESCs). The use of the human embryonic stem cell H9 (hPSC1) lines was approved by The Mount Sinai Embryonic Stem Cell Research Oversight (ESCRO) committee, which provides oversight of all issues related to derivation and use of human embryonic stem cell (hESC) lines. This error does not impact the interpretations and conclusions of the study.

UR - https://www.scopus.com/pages/publications/85196183790

U2 - 10.1038/s41586-024-07659-8

DO - 10.1038/s41586-024-07659-8

M3 - Comment/debate

AN - SCOPUS:85196183790

SN - 0028-0836

VL - 631

SP - E3

JO - Nature

JF - Nature

IS - 8019

ER -

Correction to: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Nature, (2020), 586, 7827, (113-119), 10.1038/s41586-020-2577-1)

Abstract

Access to Document

Fingerprint

Cite this